Posts Tagged ‘commercial version’

Sphere Fluidics: biotherapeutics device attracts $7m investment

Comments Off | 02-16-2016

A Cambridge life sciences company that has developed a revolutionary system for single-cell analysis in the biopharmaceutical market, with support from Innovate UK, has secured private investment totalling $7 million.
Sphere Fluidics Ltd’s Cyto-Mine® device promises to transform the discovery and development of biotherapeutics for treatment of cancer and inflammatory diseases and vaccine generation.
The company, based

Tags: , , , , , , , ,
Posted in General | Read More